Seastar Medical Holding vs Pulse Biosciences
Seastar Medical Holding is the larger business, with $1.2m of revenue in fiscal 2025 against $350,000 for Pulse Biosciences (3.5 times as much). Seastar Medical Holding kept more of each dollar of sales as profit: a net margin of -984.6% against -20794.6%.
| Latest fiscal year | Seastar Medical HoldingICU, 2025 | Pulse BiosciencesPLSE, 2025 |
|---|---|---|
| Revenue | $1.2m | $350,000 |
| Revenue growth | 814.1% | — |
| Net income | −$12.2m | −$72.8m |
| Operating margin | -986.6% | — |
| Net margin | -984.6% | -20794.6% |
| Return on equity | — | -74.4% |
| Free cash flow | — | −$54.4m |
| Cash | — | $80.7m |
| Total debt | $525,000 | $0 |
| Debt to equity | 5.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 17 | 116 |
| Market value | $8.3m | $3.66bn |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 3 buys, 0 sales | 8 buys, 7 sales |